Review article · 2026 · Open access

Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies

David J. Kuter, Sigbjørn Berentsen, Nichola Cooper, Lei Zhang, Jun Shi, Yunfei Chen, Lele Zhang, Charlie Zhou, Yanrong wang, Jaideep S. Dudani, Neelufar Mozaffarian

Blood Reviews, 76, 101387 · Published 12 March 2026 · DOI 10.1016/j.blre.2026.101387

Open full textCite this paper

In brief

“Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies” is a 2026 review article by David J. Kuter and 10 co-authors, published in Blood Reviews. OpenAlex counts 1 citations as of 20 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Blood Reviews.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.00
References
105
Authors
11

Abstract

Autoimmune cytopenias (AICs) arise from pathogenic autoantibody-mediated destruction of blood cells. Current treatments often fail to achieve durable remission, necessitating long-term treatment including immunosuppression and exposure to treatment-related toxicities. Insights into B cell biology demonstrate the central role of autoreactive B cells and plasma cells in sustaining disease activity and relapse, providing a rationale to achieve sustained, treatment-free remissions through "immune reset". This review summarizes the current understanding of immune reset in AICs and examines clinical data for depletion strategies targeting distinct stages of B cell maturation. We compare therapeutic modalities across monoclonal antibodies, bispecific T cell engagers (TCE), and chimeric antigen receptor (CAR) T cells. The depth and breadth of depletion, kinetics of immune reconstitution, and treatment-related risks are critical determinants of long-term outcome potential and individualized risk-benefit assessment. Collectively, these advances support a potential paradigm shift from chronic immunosuppression towards durable remissions off therapy with time-limited therapeutic interventions.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kuter, D. J., Berentsen, S., Cooper, N., Zhang, L., Shi, J., Chen, Y., Zhang, L., Zhou, C., wang, Y., Dudani, J. S., & Mozaffarian, N. (2026). Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies. Blood Reviews, 76, 101387. https://doi.org/10.1016/j.blre.2026.101387

MLA 9

Kuter, David J., et al. “Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies.” Blood Reviews, vol. 76, 2026, p. 101387. https://doi.org/10.1016/j.blre.2026.101387.

Chicago

Kuter, David J., Sigbjørn Berentsen, Nichola Cooper, Lei Zhang, Jun Shi, Yunfei Chen, Lele Zhang, et al. 2026. “Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies.” Blood Reviews 76: 101387. https://doi.org/10.1016/j.blre.2026.101387.

Harvard

Kuter, D. J. et al. (2026) ‘Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies’, Blood Reviews, 76, p. 101387. doi:10.1016/j.blre.2026.101387.

IEEE

D. J. Kuter et al., “Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies,” Blood Reviews, vol. 76, p. 101387, 2026, doi: 10.1016/j.blre.2026.101387.

BibTeX

@article{kuter2026towards,
  title     = {{Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies}},
  author    = {Kuter, David J. and Berentsen, Sigbjørn and Cooper, Nichola and Zhang, Lei and Shi, Jun and Chen, Yunfei and Zhang, Lele and Zhou, Charlie and wang, Yanrong and Dudani, Jaideep S. and Mozaffarian, Neelufar},
  journal   = {Blood Reviews},
  year      = {2026},
  volume    = {76},
  pages     = {101387},
  doi       = {10.1016/j.blre.2026.101387},
  url       = {https://doi.org/10.1016/j.blre.2026.101387}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Hematology › Blood groups and transfusion

  • autoimmune cytopenia
  • immune reset
  • B-cell depletion
  • autoreactive B cells
  • plasma cells
  • treatment-free remission
  • monoclonal antibodies
  • bispecific T-cell engagers

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Kuter, D. J., Berentsen, S., Cooper, N., Zhang, L., Shi, J., Chen, Y., Zhang, L., Zhou, C., wang, Y., Dudani, J. S., & Mozaffarian, N. (2026). Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies. Blood Reviews, 76, 101387. https://doi.org/10.1016/j.blre.2026.101387

How many times has this paper been cited?

1 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Blood Reviews: sign in and open the full text from this page.

Who wrote this paper?

David J. Kuter, Sigbjørn Berentsen, Nichola Cooper, Lei Zhang, Jun Shi, Yunfei Chen, Lele Zhang, Charlie Zhou, Yanrong wang, Jaideep S. Dudani, Neelufar Mozaffarian.

What is the DOI of this paper?

10.1016/j.blre.2026.101387, permanently at https://doi.org/10.1016/j.blre.2026.101387. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.